Eman Y. Ahmed

484 total citations
18 papers, 382 citations indexed

About

Eman Y. Ahmed is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eman Y. Ahmed has authored 18 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Eman Y. Ahmed's work include Synthesis and biological activity (13 papers), Synthesis of Organic Compounds (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Eman Y. Ahmed is often cited by papers focused on Synthesis and biological activity (13 papers), Synthesis of Organic Compounds (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Eman Y. Ahmed collaborates with scholars based in Egypt, United States and India. Eman Y. Ahmed's co-authors include Omaima M. Abdelhafez, Hamed I. Ali, Rasha Z. Batran, Kamelia M. Amin, Mohamed M. Abdalla, Sherien M. El‐Daly, Walaa A. El‐Kashak, Hanem M. Awad, Zakaria Y. Abd Elmageed and Toby M. Maher and has published in prestigious journals such as RSC Advances, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Eman Y. Ahmed

18 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eman Y. Ahmed Egypt 12 254 154 67 55 29 18 382
Ohoud J. Alotaibi Saudi Arabia 9 235 0.9× 197 1.3× 44 0.7× 43 0.8× 25 0.9× 9 371
Defeng Tian United States 9 206 0.8× 174 1.1× 44 0.7× 95 1.7× 31 1.1× 14 381
Taijin Wang China 10 201 0.8× 264 1.7× 124 1.9× 34 0.6× 18 0.6× 25 447
Fatima Naaz India 8 288 1.1× 159 1.0× 37 0.6× 55 1.0× 32 1.1× 12 430
Nada Aljaeed Saudi Arabia 10 210 0.8× 178 1.2× 48 0.7× 33 0.6× 17 0.6× 10 347
Mohamed Elsayed United States 11 216 0.9× 215 1.4× 57 0.9× 21 0.4× 29 1.0× 19 421
Rajesh Kakadiya Taiwan 16 506 2.0× 335 2.2× 86 1.3× 35 0.6× 37 1.3× 35 695
Heba A. Hassan Egypt 14 387 1.5× 261 1.7× 94 1.4× 36 0.7× 22 0.8× 31 595
Ching-Ping Chen Taiwan 8 359 1.4× 200 1.3× 66 1.0× 37 0.7× 42 1.4× 9 511

Countries citing papers authored by Eman Y. Ahmed

Since Specialization
Citations

This map shows the geographic impact of Eman Y. Ahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman Y. Ahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman Y. Ahmed more than expected).

Fields of papers citing papers by Eman Y. Ahmed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman Y. Ahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman Y. Ahmed. The network helps show where Eman Y. Ahmed may publish in the future.

Co-authorship network of co-authors of Eman Y. Ahmed

This figure shows the co-authorship network connecting the top 25 collaborators of Eman Y. Ahmed. A scholar is included among the top collaborators of Eman Y. Ahmed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman Y. Ahmed. Eman Y. Ahmed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abdelhafez, Omaima M., et al.. (2025). In vitro and in vivo antidiabetic evaluation of new Coumarin and Chromone derivatives: Design, synthesis and molecular modeling. Bioorganic Chemistry. 159. 108338–108338. 2 indexed citations
2.
3.
Batran, Rasha Z., et al.. (2024). Anticancer activity of new triazolopyrimidine linked coumarin and quinolone hybrids: Synthesis, molecular modeling, TrkA, PI3K/AKT and EGFR inhibition. Journal of Molecular Structure. 1305. 137790–137790. 14 indexed citations
4.
Ahmed, Eman Y., et al.. (2024). Design, synthesis and molecular docking studies of tailored coumarin and chromone derivatives for use as anti-Alzheimer agents. Journal of Molecular Structure. 1323. 140732–140732. 4 indexed citations
5.
Batran, Rasha Z., et al.. (2024). Naturally based pyrazoline derivatives as aminopeptidase N, VEGFR2 and MMP9 inhibitors: design, synthesis and molecular modeling. RSC Advances. 14(31). 22434–22448. 3 indexed citations
6.
Batran, Rasha Z., et al.. (2024). Design, synthesis and molecular modeling of pyrazoline based coumarin derivatives as tubulin polymerization inhibitors. Journal of Molecular Structure. 1318. 139123–139123. 4 indexed citations
7.
Batran, Rasha Z., et al.. (2023). EGFR and PI3K/m-TOR inhibitors: design, microwave assisted synthesis and anticancer activity of thiazole–coumarin hybrids. RSC Advances. 13(42). 29070–29085. 14 indexed citations
8.
Ahmed, Eman Y., Omaima M. Abdelhafez, Dalia Zaafar, et al.. (2022). Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives. Archiv der Pharmazie. 355(6). e2100327–e2100327. 17 indexed citations
9.
Ahmed, Eman Y., et al.. (2022). Design, synthesis, and molecular modeling of coumarin derivatives as MDM2 inhibitors targeting breast cancer. Chemical Biology & Drug Design. 99(4). 609–619. 9 indexed citations
10.
Batran, Rasha Z., Walaa A. El‐Kashak, Sherien M. El‐Daly, & Eman Y. Ahmed. (2021). Dual Kinase Inhibition of EGFR/HER2: Design, Synthesis and Molecular Docking of Thiazolylpyrazolyl‐Based Aminoquinoline Derivatives as Anticancer Agents**. ChemistrySelect. 6(40). 11012–11021. 19 indexed citations
11.
12.
Batran, Rasha Z., Sherien M. El‐Daly, Walaa A. El‐Kashak, & Eman Y. Ahmed. (2021). Design, synthesis, and molecular modeling of quinoline‐based derivatives as anti‐breast cancer agents targeting EGFR/AKT signaling pathway. Chemical Biology & Drug Design. 99(3). 470–482. 26 indexed citations
13.
Ahmed, Eman Y., et al.. (2020). VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents. Bioorganic & Medicinal Chemistry. 28(5). 115328–115328. 60 indexed citations
14.
Bhola, Patrick, Eman Y. Ahmed, Jennifer L. Guerriero, et al.. (2020). High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors. Science Signaling. 13(636). 41 indexed citations
15.
Abdelhafez, Omaima M., et al.. (2019). Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds. Bioorganic & Medicinal Chemistry. 27(7). 1308–1319. 32 indexed citations
16.
Abdelhafez, Omaima M., Hamed I. Ali, Kamelia M. Amin, Mohamed M. Abdalla, & Eman Y. Ahmed. (2015). Design, synthesis and anticancer activity of furochromone and benzofuran derivatives targeting VEGFR-2 tyrosine kinase. RSC Advances. 5(32). 25312–25324. 24 indexed citations
17.
Abdelhafez, Omaima M., Kamelia M. Amin, Hamed I. Ali, Mohamed M. Abdalla, & Eman Y. Ahmed. (2014). Design, synthesis and anticancer activity of benzofuran derivatives targeting VEGFR-2 tyrosine kinase. RSC Advances. 4(23). 11569–11569. 41 indexed citations
18.
Mohamed, Tahia K., et al.. (2009). Synthesis and antitumor activity of some new xanthotoxin derivatives. European Journal of Medicinal Chemistry. 44(7). 2967–2974. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ohoud J. Alotaibi Breakdown of academic impact, for papers by Defeng Tian Breakdown of academic impact, for papers by Taijin Wang Breakdown of academic impact, for papers by Fatima Naaz Breakdown of academic impact, for papers by Nada Aljaeed Breakdown of academic impact, for papers by Mohamed Elsayed Breakdown of academic impact, for papers by Rajesh Kakadiya Breakdown of academic impact, for papers by Heba A. Hassan Breakdown of academic impact, for papers by Ching-Ping Chen
Rankless by CCL
2026